In animal models for AD, females display learning deficits earlier than males [293] and blocking microglial proliferation with colony-stimulating factor-1 (CSF1R) inhibitors only led to a reduction in tau and to gene-expression patters similar to WT animals in females, but not in males [294]. This evidence concerns the gene MAPT and Alzheimer disease.